Información:
Error:
ID
38365
Descripción
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02183805
Link
https://clinicaltrials.gov/show/NCT02183805
Palabras clave
Versiones (1)
- 12/10/19 12/10/19 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
12 de octubre de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Carcinoma Breast Stage IV NCT02183805
Eligibility Carcinoma Breast Stage IV NCT02183805
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma Breast Stage IV NCT02183805
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ECOG performance status
Item
eastern cooperative oncology group (ecog) 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Breast Carcinoma | Recurrent disease Locally | Neoplasm Metastasis
Item
histologically or cytologically proven diagnosis of breast cancer with evidence of locally recurrent or metastatic disease.
boolean
C0678222 (UMLS CUI [1])
C0277556 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3])
C0021044 (UMLS CUI [4])
C0277556 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3])
C0021044 (UMLS CUI [4])
Estrogen receptor negative | Progesterone receptor negative | HER2/Neu Negative | FISH | Immunohistochemistry
Item
documentation of estrogen and progestin receptor (er/pr) negative status and her2/neu receptor negative status (ie, fish negative or immunohistochemistry 0 or +1).
boolean
C0279756 (UMLS CUI [1])
C0279766 (UMLS CUI [2])
C2348908 (UMLS CUI [3])
C0162789 (UMLS CUI [4])
C0021044 (UMLS CUI [5])
C0279766 (UMLS CUI [2])
C2348908 (UMLS CUI [3])
C0162789 (UMLS CUI [4])
C0021044 (UMLS CUI [5])
In complete remission | Partial response Good | Status post First line Chemotherapy
Item
obtained complete response or good partial response after first line chemotherapy.
boolean
C0677874 (UMLS CUI [1])
C1521726 (UMLS CUI [2,1])
C0205170 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C1708063 (UMLS CUI [3,2])
C0392920 (UMLS CUI [3,3])
C1521726 (UMLS CUI [2,1])
C0205170 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C1708063 (UMLS CUI [3,2])
C0392920 (UMLS CUI [3,3])
Organ function
Item
normal organ function required prior to study entry.
boolean
C0678852 (UMLS CUI [1])
Protocol Compliance
Item
willingness to comply with treatment plans and other study procedures.
boolean
C0525058 (UMLS CUI [1])
Central Nervous System Involvement Uncontrolled
Item
uncontrolled central nervous system (cns) involvement with disease
boolean
C4050309 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Childbearing Potential Contraceptive methods Unwilling
Item
fertile women unwilling to use contraceptive techniques during treatment
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Pregnancy
Item
females who are pregnant
boolean
C0032961 (UMLS CUI [1])
Organ dysfunction
Item
organ dysfunction.
boolean
C0349410 (UMLS CUI [1])
Investigational New Drugs
Item
patients may not be receiving any other investigational agents.
boolean
C0013230 (UMLS CUI [1])